Journal: Biomedicines
Article Title: Integrative RNA-Seq and TCGA-BRCA Analyses Highlight the Role of LINC01133 in Triple-Negative Breast Cancer
doi: 10.3390/biomedicines14020268
Figure Lengend Snippet: Generation and validation of the Hs578T_ko cell line. ( A ) Schematic panel of the CRISPR/Cas9-based gene editing strategy used for the knockout of LINC01133 in Hs578T_wt using lentiviral particle production in 293T cells and subsequent transduction into the target cell line. In ( B ) is shown the analysis of LINC01133 expression by qRT-PCR in the Hs578T cell lines, showing that the generated Hs578T_ko 1 + 3 cell line presented a complete knockout compared to the other strategies and the Hs578T_ctr cell line. In ( C ), we evaluated the stability of the Hs578T_ko knockout across multiple cell passages, confirming the absence or low expression of the LINC01133 transcript. In ( D ), genome editing was confirmed by PCR using internal and external primers to the LINC01133 gene locus, showing non-amplification in Hs578T + ko 1 + 3. qRT-PCRs were performed in technical and biological triplicate, using three reference genes ( HPRT1 , GAPDH , and HMBS ). Statistical analysis was performed to obtain FoldChange using the 2 −ΔΔCT method, with comparative analysis via One-Way ANOVA and multiple comparisons via Dunnett’s test, with error based on SEM. p -value: * ≤ 0.05; **** ≤ 0.0001; ns: non-significant.
Article Snippet: This study focused on the human Hs578T TNBC cell line (HTB-126, ATCC), which, unlike the human TNBC MDA-MB-231 cell line (HTB-26) that widely used in breast cancer studies, has been reported to exhibit lower expression of genes linked to proliferation pathways, such as EGF and TGF-β, in addition to exhibiting less clonal heterogeneity [ ].
Techniques: Biomarker Discovery, CRISPR, Knock-Out, Transduction, Expressing, Quantitative RT-PCR, Generated, Amplification